Vaporized Nicotine Products More Effective Than Nicotine Replacement Therapy
By Elana Gotkine HealthDay Reporter

THURSDAY, July 17, 2025 -- In a socially disadvantaged population, vaporized nicotine products (VNPs) are more effective than nicotine replacement therapy (NRT) for smoking cessation, according to a study published online July 15 in the Annals of Internal Medicine.
Ryan J. Courtney, Ph.D., from the University of New South Wales in Australia, and colleagues examined whether VNPs are more effective than NRT for smoking cessation among people experiencing social disadvantage in a two-group, open-label, randomized trial involving 1,045 adults who smoked daily. Participants were randomly assigned to a free eight-week supply of NRT or VNPs; all received text-message support.
Overall, 866 participants completed the final follow-up. The researchers found that the verified six-month continuous abstinence rate was 9.6 and 28.4 percent in the NRT and VNP groups, respectively (posterior risk difference estimate, 18.7 percent; more than 99 percent posterior probability that VNP is superior). Compared with the NRT group, self-reported adverse events occurred less often in the VNP group (355 events among 237 participants versus 442 events among 278 participants; incident rate ratio, 0.75).
"VNPs with flavor choice had greater effectiveness compared with NRT gum or lozenge when provided in combination with minimal text-message behavioral support," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-18 12:00
Read more

- U.S. Hospitals Face Shortages in Essential Staff Due to Foreign Residency Visa Delays
- Pediatric Mycoplasma Pneumoniae Infection Incidence Increased in 2024
- Mild Obstructive Sleep Apnea More Common in Female Athletes Than Expected
- Fruits And Veggies Protective Against IBD, Study Says
- Many Kids Unnecessarily Hospitalized Following Allergic Reactions
- Higher Cardiac Marker Levels Tied to Long-Term Cancer Risk
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions